Today, the CHRO of Encompass Health Corporation (NYSE: EHC), Cheryl Levy, sold shares of EHC for $1.95M.
Following Cheryl Levy’s last EHC Sell transaction on May 02, 2016, the stock climbed by 23.5%. In addition to Cheryl Levy, 2 other EHC executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Encompass Health Corporation’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $1.05 billion and quarterly net profit of $83.5 million. In comparison, last year the company earned revenue of $958 million and had a net profit of $66.6 million. EHC’s market cap is $6.29B and the company has a P/E ratio of 22.58. Currently, Encompass Health Corporation has an average volume of 127.8K.
Based on 9 analyst ratings, the analyst consensus is Strong Buy with an average price target of $65.56, reflecting a -2.8% downside.
The insider sentiment on Encompass Health Corporation has been negative according to 95 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Encompass Health Corp. is engaged in providing post-acute healthcare services. It operates through the Impatient Rehabilitation and Home Health and Hospice segments.
